Pharma & Healthcare
Global Aciclovir Market Research Report 2025
- Jul 28, 25
- ID: 409140
- Pages: 118
- Figures: 126
- Views: 3
The global market for Aciclovir was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Aciclovir (ACV), also known as acyclovir, is an antiviral medication. It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles. Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein-Barr virus infection.
North American market for Aciclovir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Aciclovir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Aciclovir include Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic, Cimed Industria de Medicamentos, Reman Drug, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aciclovir.
The Aciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Greater Pharma
LBS Labs
GlaxoSmithKline
Lex Ano
Salutas
Novartis
Teva
Stada Nordic
Cimed Industria de Medicamentos
Reman Drug
L.E.T.I.
Nichi-Iko Pharmaceutical
Choseido Pharmaceutical
Shiono Kemikaru
Towa Yakuhin
Wockhardt
Takata Pharmaceutical
Aliud
Amneal Pharma
Apotex
Arrow
Laboratoires Servier
Sanofi
Mylan
Orion Pharma
Pfizer
Segment by Type
Generic
Patent
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Aciclovir (ACV), also known as acyclovir, is an antiviral medication. It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles. Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein-Barr virus infection.
North American market for Aciclovir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Aciclovir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Aciclovir include Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic, Cimed Industria de Medicamentos, Reman Drug, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aciclovir.
The Aciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Greater Pharma
LBS Labs
GlaxoSmithKline
Lex Ano
Salutas
Novartis
Teva
Stada Nordic
Cimed Industria de Medicamentos
Reman Drug
L.E.T.I.
Nichi-Iko Pharmaceutical
Choseido Pharmaceutical
Shiono Kemikaru
Towa Yakuhin
Wockhardt
Takata Pharmaceutical
Aliud
Amneal Pharma
Apotex
Arrow
Laboratoires Servier
Sanofi
Mylan
Orion Pharma
Pfizer
Segment by Type
Generic
Patent
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Aciclovir Market Overview
1.1 Product Definition
1.2 Aciclovir by Type
1.2.1 Global Aciclovir Market Value Comparison by Type (2024 VS 2031)
1.2.2 Generic
1.2.3 Patent
1.3 Aciclovir by Application
1.3.1 Global Aciclovir Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Aciclovir Market Size Estimates and Forecasts
1.4.1 Global Aciclovir Revenue 2020-2031
1.4.2 Global Aciclovir Sales 2020-2031
1.4.3 Global Aciclovir Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Aciclovir Market Competition by Manufacturers
2.1 Global Aciclovir Sales Market Share by Manufacturers (2020-2025)
2.2 Global Aciclovir Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Aciclovir Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Aciclovir, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aciclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aciclovir, Product Type & Application
2.7 Global Key Manufacturers of Aciclovir, Date of Enter into This Industry
2.8 Global Aciclovir Market Competitive Situation and Trends
2.8.1 Global Aciclovir Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Aciclovir Players Market Share by Revenue
2.8.3 Global Aciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aciclovir Market Scenario by Region
3.1 Global Aciclovir Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Aciclovir Sales by Region: 2020-2031
3.2.1 Global Aciclovir Sales by Region: 2020-2025
3.2.2 Global Aciclovir Sales by Region: 2026-2031
3.3 Global Aciclovir Revenue by Region: 2020-2031
3.3.1 Global Aciclovir Revenue by Region: 2020-2025
3.3.2 Global Aciclovir Revenue by Region: 2026-2031
3.4 North America Aciclovir Market Facts & Figures by Country
3.4.1 North America Aciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Aciclovir Sales by Country (2020-2031)
3.4.3 North America Aciclovir Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aciclovir Market Facts & Figures by Country
3.5.1 Europe Aciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Aciclovir Sales by Country (2020-2031)
3.5.3 Europe Aciclovir Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aciclovir Market Facts & Figures by Region
3.6.1 Asia Pacific Aciclovir Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Aciclovir Sales by Region (2020-2031)
3.6.3 Asia Pacific Aciclovir Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aciclovir Market Facts & Figures by Country
3.7.1 Latin America Aciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Aciclovir Sales by Country (2020-2031)
3.7.3 Latin America Aciclovir Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aciclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Aciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Aciclovir Sales by Country (2020-2031)
3.8.3 Middle East and Africa Aciclovir Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aciclovir Sales by Type (2020-2031)
4.1.1 Global Aciclovir Sales by Type (2020-2025)
4.1.2 Global Aciclovir Sales by Type (2026-2031)
4.1.3 Global Aciclovir Sales Market Share by Type (2020-2031)
4.2 Global Aciclovir Revenue by Type (2020-2031)
4.2.1 Global Aciclovir Revenue by Type (2020-2025)
4.2.2 Global Aciclovir Revenue by Type (2026-2031)
4.2.3 Global Aciclovir Revenue Market Share by Type (2020-2031)
4.3 Global Aciclovir Price by Type (2020-2031)
5 Segment by Application
5.1 Global Aciclovir Sales by Application (2020-2031)
5.1.1 Global Aciclovir Sales by Application (2020-2025)
5.1.2 Global Aciclovir Sales by Application (2026-2031)
5.1.3 Global Aciclovir Sales Market Share by Application (2020-2031)
5.2 Global Aciclovir Revenue by Application (2020-2031)
5.2.1 Global Aciclovir Revenue by Application (2020-2025)
5.2.2 Global Aciclovir Revenue by Application (2026-2031)
5.2.3 Global Aciclovir Revenue Market Share by Application (2020-2031)
5.3 Global Aciclovir Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Greater Pharma
6.1.1 Greater Pharma Company Information
6.1.2 Greater Pharma Description and Business Overview
6.1.3 Greater Pharma Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Greater Pharma Aciclovir Product Portfolio
6.1.5 Greater Pharma Recent Developments/Updates
6.2 LBS Labs
6.2.1 LBS Labs Company Information
6.2.2 LBS Labs Description and Business Overview
6.2.3 LBS Labs Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.2.4 LBS Labs Aciclovir Product Portfolio
6.2.5 LBS Labs Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Aciclovir Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Lex Ano
6.4.1 Lex Ano Company Information
6.4.2 Lex Ano Description and Business Overview
6.4.3 Lex Ano Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lex Ano Aciclovir Product Portfolio
6.4.5 Lex Ano Recent Developments/Updates
6.5 Salutas
6.5.1 Salutas Company Information
6.5.2 Salutas Description and Business Overview
6.5.3 Salutas Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Salutas Aciclovir Product Portfolio
6.5.5 Salutas Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Aciclovir Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Teva
6.7.1 Teva Company Information
6.7.2 Teva Description and Business Overview
6.7.3 Teva Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Aciclovir Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Stada Nordic
6.8.1 Stada Nordic Company Information
6.8.2 Stada Nordic Description and Business Overview
6.8.3 Stada Nordic Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Stada Nordic Aciclovir Product Portfolio
6.8.5 Stada Nordic Recent Developments/Updates
6.9 Cimed Industria de Medicamentos
6.9.1 Cimed Industria de Medicamentos Company Information
6.9.2 Cimed Industria de Medicamentos Description and Business Overview
6.9.3 Cimed Industria de Medicamentos Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cimed Industria de Medicamentos Aciclovir Product Portfolio
6.9.5 Cimed Industria de Medicamentos Recent Developments/Updates
6.10 Reman Drug
6.10.1 Reman Drug Company Information
6.10.2 Reman Drug Description and Business Overview
6.10.3 Reman Drug Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Reman Drug Aciclovir Product Portfolio
6.10.5 Reman Drug Recent Developments/Updates
6.11 L.E.T.I.
6.11.1 L.E.T.I. Company Information
6.11.2 L.E.T.I. Description and Business Overview
6.11.3 L.E.T.I. Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.11.4 L.E.T.I. Aciclovir Product Portfolio
6.11.5 L.E.T.I. Recent Developments/Updates
6.12 Nichi-Iko Pharmaceutical
6.12.1 Nichi-Iko Pharmaceutical Company Information
6.12.2 Nichi-Iko Pharmaceutical Description and Business Overview
6.12.3 Nichi-Iko Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Nichi-Iko Pharmaceutical Aciclovir Product Portfolio
6.12.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.13 Choseido Pharmaceutical
6.13.1 Choseido Pharmaceutical Company Information
6.13.2 Choseido Pharmaceutical Description and Business Overview
6.13.3 Choseido Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Choseido Pharmaceutical Aciclovir Product Portfolio
6.13.5 Choseido Pharmaceutical Recent Developments/Updates
6.14 Shiono Kemikaru
6.14.1 Shiono Kemikaru Company Information
6.14.2 Shiono Kemikaru Description and Business Overview
6.14.3 Shiono Kemikaru Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shiono Kemikaru Aciclovir Product Portfolio
6.14.5 Shiono Kemikaru Recent Developments/Updates
6.15 Towa Yakuhin
6.15.1 Towa Yakuhin Company Information
6.15.2 Towa Yakuhin Description and Business Overview
6.15.3 Towa Yakuhin Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Towa Yakuhin Aciclovir Product Portfolio
6.15.5 Towa Yakuhin Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Company Information
6.16.2 Wockhardt Description and Business Overview
6.16.3 Wockhardt Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Wockhardt Aciclovir Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Takata Pharmaceutical
6.17.1 Takata Pharmaceutical Company Information
6.17.2 Takata Pharmaceutical Description and Business Overview
6.17.3 Takata Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Takata Pharmaceutical Aciclovir Product Portfolio
6.17.5 Takata Pharmaceutical Recent Developments/Updates
6.18 Aliud
6.18.1 Aliud Company Information
6.18.2 Aliud Description and Business Overview
6.18.3 Aliud Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Aliud Aciclovir Product Portfolio
6.18.5 Aliud Recent Developments/Updates
6.19 Amneal Pharma
6.19.1 Amneal Pharma Company Information
6.19.2 Amneal Pharma Description and Business Overview
6.19.3 Amneal Pharma Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Amneal Pharma Aciclovir Product Portfolio
6.19.5 Amneal Pharma Recent Developments/Updates
6.20 Apotex
6.20.1 Apotex Company Information
6.20.2 Apotex Description and Business Overview
6.20.3 Apotex Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Apotex Aciclovir Product Portfolio
6.20.5 Apotex Recent Developments/Updates
6.21 Arrow
6.21.1 Arrow Company Information
6.21.2 Arrow Description and Business Overview
6.21.3 Arrow Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Arrow Aciclovir Product Portfolio
6.21.5 Arrow Recent Developments/Updates
6.22 Laboratoires Servier
6.22.1 Laboratoires Servier Company Information
6.22.2 Laboratoires Servier Description and Business Overview
6.22.3 Laboratoires Servier Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Laboratoires Servier Aciclovir Product Portfolio
6.22.5 Laboratoires Servier Recent Developments/Updates
6.23 Sanofi
6.23.1 Sanofi Company Information
6.23.2 Sanofi Description and Business Overview
6.23.3 Sanofi Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Sanofi Aciclovir Product Portfolio
6.23.5 Sanofi Recent Developments/Updates
6.24 Mylan
6.24.1 Mylan Company Information
6.24.2 Mylan Description and Business Overview
6.24.3 Mylan Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Mylan Aciclovir Product Portfolio
6.24.5 Mylan Recent Developments/Updates
6.25 Orion Pharma
6.25.1 Orion Pharma Company Information
6.25.2 Orion Pharma Description and Business Overview
6.25.3 Orion Pharma Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Orion Pharma Aciclovir Product Portfolio
6.25.5 Orion Pharma Recent Developments/Updates
6.26 Pfizer
6.26.1 Pfizer Company Information
6.26.2 Pfizer Description and Business Overview
6.26.3 Pfizer Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Pfizer Aciclovir Product Portfolio
6.26.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aciclovir Industry Chain Analysis
7.2 Aciclovir Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aciclovir Production Mode & Process Analysis
7.4 Aciclovir Sales and Marketing
7.4.1 Aciclovir Sales Channels
7.4.2 Aciclovir Distributors
7.5 Aciclovir Customer Analysis
8 Aciclovir Market Dynamics
8.1 Aciclovir Industry Trends
8.2 Aciclovir Market Drivers
8.3 Aciclovir Market Challenges
8.4 Aciclovir Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Aciclovir by Type
1.2.1 Global Aciclovir Market Value Comparison by Type (2024 VS 2031)
1.2.2 Generic
1.2.3 Patent
1.3 Aciclovir by Application
1.3.1 Global Aciclovir Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Aciclovir Market Size Estimates and Forecasts
1.4.1 Global Aciclovir Revenue 2020-2031
1.4.2 Global Aciclovir Sales 2020-2031
1.4.3 Global Aciclovir Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Aciclovir Market Competition by Manufacturers
2.1 Global Aciclovir Sales Market Share by Manufacturers (2020-2025)
2.2 Global Aciclovir Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Aciclovir Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Aciclovir, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aciclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aciclovir, Product Type & Application
2.7 Global Key Manufacturers of Aciclovir, Date of Enter into This Industry
2.8 Global Aciclovir Market Competitive Situation and Trends
2.8.1 Global Aciclovir Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Aciclovir Players Market Share by Revenue
2.8.3 Global Aciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aciclovir Market Scenario by Region
3.1 Global Aciclovir Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Aciclovir Sales by Region: 2020-2031
3.2.1 Global Aciclovir Sales by Region: 2020-2025
3.2.2 Global Aciclovir Sales by Region: 2026-2031
3.3 Global Aciclovir Revenue by Region: 2020-2031
3.3.1 Global Aciclovir Revenue by Region: 2020-2025
3.3.2 Global Aciclovir Revenue by Region: 2026-2031
3.4 North America Aciclovir Market Facts & Figures by Country
3.4.1 North America Aciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Aciclovir Sales by Country (2020-2031)
3.4.3 North America Aciclovir Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aciclovir Market Facts & Figures by Country
3.5.1 Europe Aciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Aciclovir Sales by Country (2020-2031)
3.5.3 Europe Aciclovir Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aciclovir Market Facts & Figures by Region
3.6.1 Asia Pacific Aciclovir Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Aciclovir Sales by Region (2020-2031)
3.6.3 Asia Pacific Aciclovir Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aciclovir Market Facts & Figures by Country
3.7.1 Latin America Aciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Aciclovir Sales by Country (2020-2031)
3.7.3 Latin America Aciclovir Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aciclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Aciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Aciclovir Sales by Country (2020-2031)
3.8.3 Middle East and Africa Aciclovir Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aciclovir Sales by Type (2020-2031)
4.1.1 Global Aciclovir Sales by Type (2020-2025)
4.1.2 Global Aciclovir Sales by Type (2026-2031)
4.1.3 Global Aciclovir Sales Market Share by Type (2020-2031)
4.2 Global Aciclovir Revenue by Type (2020-2031)
4.2.1 Global Aciclovir Revenue by Type (2020-2025)
4.2.2 Global Aciclovir Revenue by Type (2026-2031)
4.2.3 Global Aciclovir Revenue Market Share by Type (2020-2031)
4.3 Global Aciclovir Price by Type (2020-2031)
5 Segment by Application
5.1 Global Aciclovir Sales by Application (2020-2031)
5.1.1 Global Aciclovir Sales by Application (2020-2025)
5.1.2 Global Aciclovir Sales by Application (2026-2031)
5.1.3 Global Aciclovir Sales Market Share by Application (2020-2031)
5.2 Global Aciclovir Revenue by Application (2020-2031)
5.2.1 Global Aciclovir Revenue by Application (2020-2025)
5.2.2 Global Aciclovir Revenue by Application (2026-2031)
5.2.3 Global Aciclovir Revenue Market Share by Application (2020-2031)
5.3 Global Aciclovir Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Greater Pharma
6.1.1 Greater Pharma Company Information
6.1.2 Greater Pharma Description and Business Overview
6.1.3 Greater Pharma Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Greater Pharma Aciclovir Product Portfolio
6.1.5 Greater Pharma Recent Developments/Updates
6.2 LBS Labs
6.2.1 LBS Labs Company Information
6.2.2 LBS Labs Description and Business Overview
6.2.3 LBS Labs Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.2.4 LBS Labs Aciclovir Product Portfolio
6.2.5 LBS Labs Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Aciclovir Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Lex Ano
6.4.1 Lex Ano Company Information
6.4.2 Lex Ano Description and Business Overview
6.4.3 Lex Ano Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lex Ano Aciclovir Product Portfolio
6.4.5 Lex Ano Recent Developments/Updates
6.5 Salutas
6.5.1 Salutas Company Information
6.5.2 Salutas Description and Business Overview
6.5.3 Salutas Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Salutas Aciclovir Product Portfolio
6.5.5 Salutas Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Aciclovir Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Teva
6.7.1 Teva Company Information
6.7.2 Teva Description and Business Overview
6.7.3 Teva Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Aciclovir Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Stada Nordic
6.8.1 Stada Nordic Company Information
6.8.2 Stada Nordic Description and Business Overview
6.8.3 Stada Nordic Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Stada Nordic Aciclovir Product Portfolio
6.8.5 Stada Nordic Recent Developments/Updates
6.9 Cimed Industria de Medicamentos
6.9.1 Cimed Industria de Medicamentos Company Information
6.9.2 Cimed Industria de Medicamentos Description and Business Overview
6.9.3 Cimed Industria de Medicamentos Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cimed Industria de Medicamentos Aciclovir Product Portfolio
6.9.5 Cimed Industria de Medicamentos Recent Developments/Updates
6.10 Reman Drug
6.10.1 Reman Drug Company Information
6.10.2 Reman Drug Description and Business Overview
6.10.3 Reman Drug Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Reman Drug Aciclovir Product Portfolio
6.10.5 Reman Drug Recent Developments/Updates
6.11 L.E.T.I.
6.11.1 L.E.T.I. Company Information
6.11.2 L.E.T.I. Description and Business Overview
6.11.3 L.E.T.I. Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.11.4 L.E.T.I. Aciclovir Product Portfolio
6.11.5 L.E.T.I. Recent Developments/Updates
6.12 Nichi-Iko Pharmaceutical
6.12.1 Nichi-Iko Pharmaceutical Company Information
6.12.2 Nichi-Iko Pharmaceutical Description and Business Overview
6.12.3 Nichi-Iko Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Nichi-Iko Pharmaceutical Aciclovir Product Portfolio
6.12.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.13 Choseido Pharmaceutical
6.13.1 Choseido Pharmaceutical Company Information
6.13.2 Choseido Pharmaceutical Description and Business Overview
6.13.3 Choseido Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Choseido Pharmaceutical Aciclovir Product Portfolio
6.13.5 Choseido Pharmaceutical Recent Developments/Updates
6.14 Shiono Kemikaru
6.14.1 Shiono Kemikaru Company Information
6.14.2 Shiono Kemikaru Description and Business Overview
6.14.3 Shiono Kemikaru Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shiono Kemikaru Aciclovir Product Portfolio
6.14.5 Shiono Kemikaru Recent Developments/Updates
6.15 Towa Yakuhin
6.15.1 Towa Yakuhin Company Information
6.15.2 Towa Yakuhin Description and Business Overview
6.15.3 Towa Yakuhin Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Towa Yakuhin Aciclovir Product Portfolio
6.15.5 Towa Yakuhin Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Company Information
6.16.2 Wockhardt Description and Business Overview
6.16.3 Wockhardt Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Wockhardt Aciclovir Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Takata Pharmaceutical
6.17.1 Takata Pharmaceutical Company Information
6.17.2 Takata Pharmaceutical Description and Business Overview
6.17.3 Takata Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Takata Pharmaceutical Aciclovir Product Portfolio
6.17.5 Takata Pharmaceutical Recent Developments/Updates
6.18 Aliud
6.18.1 Aliud Company Information
6.18.2 Aliud Description and Business Overview
6.18.3 Aliud Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Aliud Aciclovir Product Portfolio
6.18.5 Aliud Recent Developments/Updates
6.19 Amneal Pharma
6.19.1 Amneal Pharma Company Information
6.19.2 Amneal Pharma Description and Business Overview
6.19.3 Amneal Pharma Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Amneal Pharma Aciclovir Product Portfolio
6.19.5 Amneal Pharma Recent Developments/Updates
6.20 Apotex
6.20.1 Apotex Company Information
6.20.2 Apotex Description and Business Overview
6.20.3 Apotex Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Apotex Aciclovir Product Portfolio
6.20.5 Apotex Recent Developments/Updates
6.21 Arrow
6.21.1 Arrow Company Information
6.21.2 Arrow Description and Business Overview
6.21.3 Arrow Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Arrow Aciclovir Product Portfolio
6.21.5 Arrow Recent Developments/Updates
6.22 Laboratoires Servier
6.22.1 Laboratoires Servier Company Information
6.22.2 Laboratoires Servier Description and Business Overview
6.22.3 Laboratoires Servier Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Laboratoires Servier Aciclovir Product Portfolio
6.22.5 Laboratoires Servier Recent Developments/Updates
6.23 Sanofi
6.23.1 Sanofi Company Information
6.23.2 Sanofi Description and Business Overview
6.23.3 Sanofi Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Sanofi Aciclovir Product Portfolio
6.23.5 Sanofi Recent Developments/Updates
6.24 Mylan
6.24.1 Mylan Company Information
6.24.2 Mylan Description and Business Overview
6.24.3 Mylan Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Mylan Aciclovir Product Portfolio
6.24.5 Mylan Recent Developments/Updates
6.25 Orion Pharma
6.25.1 Orion Pharma Company Information
6.25.2 Orion Pharma Description and Business Overview
6.25.3 Orion Pharma Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Orion Pharma Aciclovir Product Portfolio
6.25.5 Orion Pharma Recent Developments/Updates
6.26 Pfizer
6.26.1 Pfizer Company Information
6.26.2 Pfizer Description and Business Overview
6.26.3 Pfizer Aciclovir Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Pfizer Aciclovir Product Portfolio
6.26.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aciclovir Industry Chain Analysis
7.2 Aciclovir Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aciclovir Production Mode & Process Analysis
7.4 Aciclovir Sales and Marketing
7.4.1 Aciclovir Sales Channels
7.4.2 Aciclovir Distributors
7.5 Aciclovir Customer Analysis
8 Aciclovir Market Dynamics
8.1 Aciclovir Industry Trends
8.2 Aciclovir Market Drivers
8.3 Aciclovir Market Challenges
8.4 Aciclovir Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Aciclovir Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Aciclovir Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Aciclovir Market Competitive Situation by Manufacturers in 2024
Table 4. Global Aciclovir Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Aciclovir Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Aciclovir Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Aciclovir Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Aciclovir Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Aciclovir, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Aciclovir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aciclovir, Product Type & Application
Table 12. Global Key Manufacturers of Aciclovir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aciclovir as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aciclovir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Aciclovir Sales by Region (2020-2025) & (K Units)
Table 18. Global Aciclovir Sales Market Share by Region (2020-2025)
Table 19. Global Aciclovir Sales by Region (2026-2031) & (K Units)
Table 20. Global Aciclovir Sales Market Share by Region (2026-2031)
Table 21. Global Aciclovir Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Aciclovir Revenue Market Share by Region (2020-2025)
Table 23. Global Aciclovir Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Aciclovir Revenue Market Share by Region (2026-2031)
Table 25. North America Aciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Aciclovir Sales by Country (2020-2025) & (K Units)
Table 27. North America Aciclovir Sales by Country (2026-2031) & (K Units)
Table 28. North America Aciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Aciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Aciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Aciclovir Sales by Country (2020-2025) & (K Units)
Table 32. Europe Aciclovir Sales by Country (2026-2031) & (K Units)
Table 33. Europe Aciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Aciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Aciclovir Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Aciclovir Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Aciclovir Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Aciclovir Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Aciclovir Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Aciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Aciclovir Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Aciclovir Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Aciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Aciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Aciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Aciclovir Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Aciclovir Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Aciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Aciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Aciclovir Sales (K Units) by Type (2020-2025)
Table 51. Global Aciclovir Sales (K Units) by Type (2026-2031)
Table 52. Global Aciclovir Sales Market Share by Type (2020-2025)
Table 53. Global Aciclovir Sales Market Share by Type (2026-2031)
Table 54. Global Aciclovir Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Aciclovir Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Aciclovir Revenue Market Share by Type (2020-2025)
Table 57. Global Aciclovir Revenue Market Share by Type (2026-2031)
Table 58. Global Aciclovir Price (US$/Unit) by Type (2020-2025)
Table 59. Global Aciclovir Price (US$/Unit) by Type (2026-2031)
Table 60. Global Aciclovir Sales (K Units) by Application (2020-2025)
Table 61. Global Aciclovir Sales (K Units) by Application (2026-2031)
Table 62. Global Aciclovir Sales Market Share by Application (2020-2025)
Table 63. Global Aciclovir Sales Market Share by Application (2026-2031)
Table 64. Global Aciclovir Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Aciclovir Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Aciclovir Revenue Market Share by Application (2020-2025)
Table 67. Global Aciclovir Revenue Market Share by Application (2026-2031)
Table 68. Global Aciclovir Price (US$/Unit) by Application (2020-2025)
Table 69. Global Aciclovir Price (US$/Unit) by Application (2026-2031)
Table 70. Greater Pharma Company Information
Table 71. Greater Pharma Description and Business Overview
Table 72. Greater Pharma Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Greater Pharma Aciclovir Product
Table 74. Greater Pharma Recent Developments/Updates
Table 75. LBS Labs Company Information
Table 76. LBS Labs Description and Business Overview
Table 77. LBS Labs Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. LBS Labs Aciclovir Product
Table 79. LBS Labs Recent Developments/Updates
Table 80. GlaxoSmithKline Company Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Aciclovir Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Lex Ano Company Information
Table 86. Lex Ano Description and Business Overview
Table 87. Lex Ano Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lex Ano Aciclovir Product
Table 89. Lex Ano Recent Developments/Updates
Table 90. Salutas Company Information
Table 91. Salutas Description and Business Overview
Table 92. Salutas Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Salutas Aciclovir Product
Table 94. Salutas Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Novartis Aciclovir Product
Table 99. Novartis Recent Developments/Updates
Table 100. Teva Company Information
Table 101. Teva Description and Business Overview
Table 102. Teva Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Teva Aciclovir Product
Table 104. Teva Recent Developments/Updates
Table 105. Stada Nordic Company Information
Table 106. Stada Nordic Description and Business Overview
Table 107. Stada Nordic Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Stada Nordic Aciclovir Product
Table 109. Stada Nordic Recent Developments/Updates
Table 110. Cimed Industria de Medicamentos Company Information
Table 111. Cimed Industria de Medicamentos Description and Business Overview
Table 112. Cimed Industria de Medicamentos Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cimed Industria de Medicamentos Aciclovir Product
Table 114. Cimed Industria de Medicamentos Recent Developments/Updates
Table 115. Reman Drug Company Information
Table 116. Reman Drug Description and Business Overview
Table 117. Reman Drug Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Reman Drug Aciclovir Product
Table 119. Reman Drug Recent Developments/Updates
Table 120. L.E.T.I. Company Information
Table 121. L.E.T.I. Description and Business Overview
Table 122. L.E.T.I. Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. L.E.T.I. Aciclovir Product
Table 124. L.E.T.I. Recent Developments/Updates
Table 125. Nichi-Iko Pharmaceutical Company Information
Table 126. Nichi-Iko Pharmaceutical Description and Business Overview
Table 127. Nichi-Iko Pharmaceutical Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Nichi-Iko Pharmaceutical Aciclovir Product
Table 129. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 130. Choseido Pharmaceutical Company Information
Table 131. Choseido Pharmaceutical Description and Business Overview
Table 132. Choseido Pharmaceutical Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Choseido Pharmaceutical Aciclovir Product
Table 134. Choseido Pharmaceutical Recent Developments/Updates
Table 135. Shiono Kemikaru Company Information
Table 136. Shiono Kemikaru Description and Business Overview
Table 137. Shiono Kemikaru Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shiono Kemikaru Aciclovir Product
Table 139. Shiono Kemikaru Recent Developments/Updates
Table 140. Towa Yakuhin Company Information
Table 141. Towa Yakuhin Description and Business Overview
Table 142. Towa Yakuhin Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Towa Yakuhin Aciclovir Product
Table 144. Towa Yakuhin Recent Developments/Updates
Table 145. Wockhardt Company Information
Table 146. Wockhardt Description and Business Overview
Table 147. Wockhardt Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Wockhardt Aciclovir Product
Table 149. Wockhardt Recent Developments/Updates
Table 150. Takata Pharmaceutical Company Information
Table 151. Takata Pharmaceutical Description and Business Overview
Table 152. Takata Pharmaceutical Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Takata Pharmaceutical Aciclovir Product
Table 154. Takata Pharmaceutical Recent Developments/Updates
Table 155. Aliud Company Information
Table 156. Aliud Description and Business Overview
Table 157. Aliud Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Aliud Aciclovir Product
Table 159. Aliud Recent Developments/Updates
Table 160. Amneal Pharma Company Information
Table 161. Amneal Pharma Description and Business Overview
Table 162. Amneal Pharma Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Amneal Pharma Aciclovir Product
Table 164. Amneal Pharma Recent Developments/Updates
Table 165. Apotex Company Information
Table 166. Apotex Description and Business Overview
Table 167. Apotex Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Apotex Aciclovir Product
Table 169. Apotex Recent Developments/Updates
Table 170. Arrow Company Information
Table 171. Arrow Description and Business Overview
Table 172. Arrow Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Arrow Aciclovir Product
Table 174. Arrow Recent Developments/Updates
Table 175. Laboratoires Servier Company Information
Table 176. Laboratoires Servier Description and Business Overview
Table 177. Laboratoires Servier Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Laboratoires Servier Aciclovir Product
Table 179. Laboratoires Servier Recent Developments/Updates
Table 180. Sanofi Company Information
Table 181. Sanofi Description and Business Overview
Table 182. Sanofi Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Sanofi Aciclovir Product
Table 184. Sanofi Recent Developments/Updates
Table 185. Mylan Company Information
Table 186. Mylan Description and Business Overview
Table 187. Mylan Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Mylan Aciclovir Product
Table 189. Mylan Recent Developments/Updates
Table 190. Orion Pharma Company Information
Table 191. Orion Pharma Description and Business Overview
Table 192. Orion Pharma Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. Orion Pharma Aciclovir Product
Table 194. Orion Pharma Recent Developments/Updates
Table 195. Pfizer Company Information
Table 196. Pfizer Description and Business Overview
Table 197. Pfizer Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 198. Pfizer Aciclovir Product
Table 199. Pfizer Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Aciclovir Distributors List
Table 203. Aciclovir Customers List
Table 204. Aciclovir Market Trends
Table 205. Aciclovir Market Drivers
Table 206. Aciclovir Market Challenges
Table 207. Aciclovir Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
Table 211. Authors List of This Report
List of Figures
Figure 1. Product Picture of Aciclovir
Figure 2. Global Aciclovir Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Aciclovir Market Share by Type: 2024 & 2031
Figure 4. Generic Product Picture
Figure 5. Patent Product Picture
Figure 6. Global Aciclovir Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Aciclovir Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Global Aciclovir Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Aciclovir Market Size (2020-2031) & (US$ Million)
Figure 12. Global Aciclovir Sales (2020-2031) & (K Units)
Figure 13. Global Aciclovir Average Price (US$/Unit) & (2020-2031)
Figure 14. Aciclovir Report Years Considered
Figure 15. Aciclovir Sales Share by Manufacturers in 2024
Figure 16. Global Aciclovir Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Aciclovir Players: Market Share by Revenue in Aciclovir in 2024
Figure 18. Aciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Aciclovir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Aciclovir Sales Market Share by Country (2020-2031)
Figure 21. North America Aciclovir Revenue Market Share by Country (2020-2031)
Figure 22. United States Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Aciclovir Sales Market Share by Country (2020-2031)
Figure 25. Europe Aciclovir Revenue Market Share by Country (2020-2031)
Figure 26. Germany Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Aciclovir Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Aciclovir Revenue Market Share by Region (2020-2031)
Figure 33. China Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Aciclovir Sales Market Share by Country (2020-2031)
Figure 43. Latin America Aciclovir Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Aciclovir Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Aciclovir Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Aciclovir by Type (2020-2031)
Figure 53. Global Revenue Market Share of Aciclovir by Type (2020-2031)
Figure 54. Global Aciclovir Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Aciclovir by Application (2020-2031)
Figure 56. Global Revenue Market Share of Aciclovir by Application (2020-2031)
Figure 57. Global Aciclovir Price (US$/Unit) by Application (2020-2031)
Figure 58. Aciclovir Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Aciclovir Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Aciclovir Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Aciclovir Market Competitive Situation by Manufacturers in 2024
Table 4. Global Aciclovir Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Aciclovir Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Aciclovir Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Aciclovir Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Aciclovir Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Aciclovir, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Aciclovir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aciclovir, Product Type & Application
Table 12. Global Key Manufacturers of Aciclovir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aciclovir as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aciclovir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Aciclovir Sales by Region (2020-2025) & (K Units)
Table 18. Global Aciclovir Sales Market Share by Region (2020-2025)
Table 19. Global Aciclovir Sales by Region (2026-2031) & (K Units)
Table 20. Global Aciclovir Sales Market Share by Region (2026-2031)
Table 21. Global Aciclovir Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Aciclovir Revenue Market Share by Region (2020-2025)
Table 23. Global Aciclovir Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Aciclovir Revenue Market Share by Region (2026-2031)
Table 25. North America Aciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Aciclovir Sales by Country (2020-2025) & (K Units)
Table 27. North America Aciclovir Sales by Country (2026-2031) & (K Units)
Table 28. North America Aciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Aciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Aciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Aciclovir Sales by Country (2020-2025) & (K Units)
Table 32. Europe Aciclovir Sales by Country (2026-2031) & (K Units)
Table 33. Europe Aciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Aciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Aciclovir Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Aciclovir Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Aciclovir Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Aciclovir Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Aciclovir Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Aciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Aciclovir Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Aciclovir Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Aciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Aciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Aciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Aciclovir Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Aciclovir Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Aciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Aciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Aciclovir Sales (K Units) by Type (2020-2025)
Table 51. Global Aciclovir Sales (K Units) by Type (2026-2031)
Table 52. Global Aciclovir Sales Market Share by Type (2020-2025)
Table 53. Global Aciclovir Sales Market Share by Type (2026-2031)
Table 54. Global Aciclovir Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Aciclovir Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Aciclovir Revenue Market Share by Type (2020-2025)
Table 57. Global Aciclovir Revenue Market Share by Type (2026-2031)
Table 58. Global Aciclovir Price (US$/Unit) by Type (2020-2025)
Table 59. Global Aciclovir Price (US$/Unit) by Type (2026-2031)
Table 60. Global Aciclovir Sales (K Units) by Application (2020-2025)
Table 61. Global Aciclovir Sales (K Units) by Application (2026-2031)
Table 62. Global Aciclovir Sales Market Share by Application (2020-2025)
Table 63. Global Aciclovir Sales Market Share by Application (2026-2031)
Table 64. Global Aciclovir Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Aciclovir Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Aciclovir Revenue Market Share by Application (2020-2025)
Table 67. Global Aciclovir Revenue Market Share by Application (2026-2031)
Table 68. Global Aciclovir Price (US$/Unit) by Application (2020-2025)
Table 69. Global Aciclovir Price (US$/Unit) by Application (2026-2031)
Table 70. Greater Pharma Company Information
Table 71. Greater Pharma Description and Business Overview
Table 72. Greater Pharma Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Greater Pharma Aciclovir Product
Table 74. Greater Pharma Recent Developments/Updates
Table 75. LBS Labs Company Information
Table 76. LBS Labs Description and Business Overview
Table 77. LBS Labs Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. LBS Labs Aciclovir Product
Table 79. LBS Labs Recent Developments/Updates
Table 80. GlaxoSmithKline Company Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Aciclovir Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Lex Ano Company Information
Table 86. Lex Ano Description and Business Overview
Table 87. Lex Ano Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lex Ano Aciclovir Product
Table 89. Lex Ano Recent Developments/Updates
Table 90. Salutas Company Information
Table 91. Salutas Description and Business Overview
Table 92. Salutas Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Salutas Aciclovir Product
Table 94. Salutas Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Novartis Aciclovir Product
Table 99. Novartis Recent Developments/Updates
Table 100. Teva Company Information
Table 101. Teva Description and Business Overview
Table 102. Teva Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Teva Aciclovir Product
Table 104. Teva Recent Developments/Updates
Table 105. Stada Nordic Company Information
Table 106. Stada Nordic Description and Business Overview
Table 107. Stada Nordic Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Stada Nordic Aciclovir Product
Table 109. Stada Nordic Recent Developments/Updates
Table 110. Cimed Industria de Medicamentos Company Information
Table 111. Cimed Industria de Medicamentos Description and Business Overview
Table 112. Cimed Industria de Medicamentos Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cimed Industria de Medicamentos Aciclovir Product
Table 114. Cimed Industria de Medicamentos Recent Developments/Updates
Table 115. Reman Drug Company Information
Table 116. Reman Drug Description and Business Overview
Table 117. Reman Drug Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Reman Drug Aciclovir Product
Table 119. Reman Drug Recent Developments/Updates
Table 120. L.E.T.I. Company Information
Table 121. L.E.T.I. Description and Business Overview
Table 122. L.E.T.I. Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. L.E.T.I. Aciclovir Product
Table 124. L.E.T.I. Recent Developments/Updates
Table 125. Nichi-Iko Pharmaceutical Company Information
Table 126. Nichi-Iko Pharmaceutical Description and Business Overview
Table 127. Nichi-Iko Pharmaceutical Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Nichi-Iko Pharmaceutical Aciclovir Product
Table 129. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 130. Choseido Pharmaceutical Company Information
Table 131. Choseido Pharmaceutical Description and Business Overview
Table 132. Choseido Pharmaceutical Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Choseido Pharmaceutical Aciclovir Product
Table 134. Choseido Pharmaceutical Recent Developments/Updates
Table 135. Shiono Kemikaru Company Information
Table 136. Shiono Kemikaru Description and Business Overview
Table 137. Shiono Kemikaru Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shiono Kemikaru Aciclovir Product
Table 139. Shiono Kemikaru Recent Developments/Updates
Table 140. Towa Yakuhin Company Information
Table 141. Towa Yakuhin Description and Business Overview
Table 142. Towa Yakuhin Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Towa Yakuhin Aciclovir Product
Table 144. Towa Yakuhin Recent Developments/Updates
Table 145. Wockhardt Company Information
Table 146. Wockhardt Description and Business Overview
Table 147. Wockhardt Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Wockhardt Aciclovir Product
Table 149. Wockhardt Recent Developments/Updates
Table 150. Takata Pharmaceutical Company Information
Table 151. Takata Pharmaceutical Description and Business Overview
Table 152. Takata Pharmaceutical Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Takata Pharmaceutical Aciclovir Product
Table 154. Takata Pharmaceutical Recent Developments/Updates
Table 155. Aliud Company Information
Table 156. Aliud Description and Business Overview
Table 157. Aliud Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Aliud Aciclovir Product
Table 159. Aliud Recent Developments/Updates
Table 160. Amneal Pharma Company Information
Table 161. Amneal Pharma Description and Business Overview
Table 162. Amneal Pharma Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Amneal Pharma Aciclovir Product
Table 164. Amneal Pharma Recent Developments/Updates
Table 165. Apotex Company Information
Table 166. Apotex Description and Business Overview
Table 167. Apotex Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Apotex Aciclovir Product
Table 169. Apotex Recent Developments/Updates
Table 170. Arrow Company Information
Table 171. Arrow Description and Business Overview
Table 172. Arrow Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Arrow Aciclovir Product
Table 174. Arrow Recent Developments/Updates
Table 175. Laboratoires Servier Company Information
Table 176. Laboratoires Servier Description and Business Overview
Table 177. Laboratoires Servier Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Laboratoires Servier Aciclovir Product
Table 179. Laboratoires Servier Recent Developments/Updates
Table 180. Sanofi Company Information
Table 181. Sanofi Description and Business Overview
Table 182. Sanofi Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Sanofi Aciclovir Product
Table 184. Sanofi Recent Developments/Updates
Table 185. Mylan Company Information
Table 186. Mylan Description and Business Overview
Table 187. Mylan Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Mylan Aciclovir Product
Table 189. Mylan Recent Developments/Updates
Table 190. Orion Pharma Company Information
Table 191. Orion Pharma Description and Business Overview
Table 192. Orion Pharma Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. Orion Pharma Aciclovir Product
Table 194. Orion Pharma Recent Developments/Updates
Table 195. Pfizer Company Information
Table 196. Pfizer Description and Business Overview
Table 197. Pfizer Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 198. Pfizer Aciclovir Product
Table 199. Pfizer Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Aciclovir Distributors List
Table 203. Aciclovir Customers List
Table 204. Aciclovir Market Trends
Table 205. Aciclovir Market Drivers
Table 206. Aciclovir Market Challenges
Table 207. Aciclovir Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
Table 211. Authors List of This Report
List of Figures
Figure 1. Product Picture of Aciclovir
Figure 2. Global Aciclovir Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Aciclovir Market Share by Type: 2024 & 2031
Figure 4. Generic Product Picture
Figure 5. Patent Product Picture
Figure 6. Global Aciclovir Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Aciclovir Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Global Aciclovir Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Aciclovir Market Size (2020-2031) & (US$ Million)
Figure 12. Global Aciclovir Sales (2020-2031) & (K Units)
Figure 13. Global Aciclovir Average Price (US$/Unit) & (2020-2031)
Figure 14. Aciclovir Report Years Considered
Figure 15. Aciclovir Sales Share by Manufacturers in 2024
Figure 16. Global Aciclovir Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Aciclovir Players: Market Share by Revenue in Aciclovir in 2024
Figure 18. Aciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Aciclovir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Aciclovir Sales Market Share by Country (2020-2031)
Figure 21. North America Aciclovir Revenue Market Share by Country (2020-2031)
Figure 22. United States Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Aciclovir Sales Market Share by Country (2020-2031)
Figure 25. Europe Aciclovir Revenue Market Share by Country (2020-2031)
Figure 26. Germany Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Aciclovir Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Aciclovir Revenue Market Share by Region (2020-2031)
Figure 33. China Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Aciclovir Sales Market Share by Country (2020-2031)
Figure 43. Latin America Aciclovir Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Aciclovir Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Aciclovir Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Aciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Aciclovir by Type (2020-2031)
Figure 53. Global Revenue Market Share of Aciclovir by Type (2020-2031)
Figure 54. Global Aciclovir Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Aciclovir by Application (2020-2031)
Figure 56. Global Revenue Market Share of Aciclovir by Application (2020-2031)
Figure 57. Global Aciclovir Price (US$/Unit) by Application (2020-2031)
Figure 58. Aciclovir Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232